| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Hcw Biologics Inc. (HCWB) has 3 insiders with recent SEC Form 4 filings, including 19 buys and 0 sells. HCWB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 501.9K | $165.0K | - | |
| Dir | 25.5K | $8.4K | - | |
| Dir | 4.1K | $1.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2023 | Winer Gary M60 | Director | Buy | 1,587 | $2.05 | $3,255.91 | +2.5% | -41.8% | -71.4% | |
| Sep 13, 2023 | Byam Rebecca | Chief Financial Officer | Buy | 5,000 | $2.10 | $10,490.00 | +0.9% | -45.5% | -71.7% | |
| Sep 12, 2023 | Byam Rebecca | Chief Financial Officer | Buy | 10,000 | $2.07 | $20,715.00 | +0.9% | -44.8% | -72.9% | |
| Sep 12, 2023 | Winer Gary M60 | Director | Buy | 600 | $2.05 | $1,229.80 | +1.3% | -44.8% | -72.9% | |
| Sep 8, 2023 | Byam Rebecca | Chief Financial Officer | Buy | 10,000 | $1.99 | $19,853.00 | +0.9% | -46.3% | -65.7% | |
| Sep 7, 2023 | Winer Gary M60 | Director | Buy | 463 | $1.78 | $822.85 | +1.6% | -43.6% | -63.9% | |
| Sep 6, 2023 | Byam Rebecca | Chief Financial Officer | Buy | 5,000 | $1.95 | $9,749.00 | +0.9% | -39.7% | -70.4% | |
| Jun 9, 2023 | Byam Rebecca | Chief Financial Officer | Buy | 20,000 | $2.06 | $41,286.00 | +3.8% | -3.5% | -48.5% | |
| Jun 8, 2023 | Flowers Lee | SVP Of Business Development | Buy | 10,000 | $2.16 | $21,574.00 | +9.9% | -12.1% | -51.6% | |
| Jun 8, 2023 | Byam Rebecca | Chief Financial Officer | Buy | 24,696 | $2.07 | $51,019.55 | +2.4% | -12.1% | -51.6% |